It is well established that the principal anti-yglobulin factors in the sera of patients with rheumatoid arthritis detected by such commonly employed procedures as the sensitized sheep cell agglutination and latex fixation tests are immunoglobulins of the yM (19 S y-globulin) (2) class (3) (4) (5) (6) . These anti-y-globulins, often referred to as rheumatoid factors, are not limited in occurrence to rheumatoid arthritis, but are sometimes found in a variety of other disease states (7) (8) (9) (10) . Extensive evidence is now available in support of the concept that these factors are indeed antibodies to various antigenic determinants on the yG (7 S y-globulin) (2) molecule. This evidence has been reviewed by Kunkel (11, 12) .
Certain sera having high titers of anti-y-globulin activity contain significant quantities of materials sedimenting at a rate intermediate to the 7 and 19 S components (13, 14) . Such sera have been encountered in patients having rheumatoid arthritis or a number of other disorders (13) (14) (15) . These materials were shown to be complexes of yG that are readily dissociated in acid buffer or urea (14) . It seemed possible that the complexes might represent antigen-antibody complexes of the y-globulinanti-y-globulin type. This possibility was supported by the subsequent demonstration of a low molecular weight anti-y-globulin activity in such were made 0.1 M concentrations with respect to 2-mercaptoethanol and allowed to stand at room temperature for 3 hours or were dialyzed against 0.1 M mercaptoethanol in pH 7.5 buffer for 16 hours. At the end of the reduction period all samples were dialyzed against 0.02 M iodoacetamide in pH 7.5 buffer and then buffer.
The preparations containing intermediate complexes were digested by pepsin at pH 4.1 according to the procedure of Nisonoff, Wissler, Lipman, and Woernley (18) . The ratio of substrate to enzyme employed was 100: 1. Digestion' mixtures were incubated for 16 to 18 hours at 370 C. Digestion was terminated by dialysis against pH 7.5 sodium phosphate buffer, 0.2 ionic strength, in the cold. The fragments obtained by this procedure will be referred to as F(ab')2-fragments.
Ultracentrifugal analysis was carried out in a Spinco model E ultracentrifuge with double sector 12-mm cells. Plate measurements were made according to the procedures described by Schachman (21) or Markham (22) . The sedimentation coefficients were corrected to the Saow values by the accepted procedures. The partial specific volumes were assumed to be 0.73.
Density gradient ultracentrifugation was performed according to the general methods described by Kunkel (23) .
Continuous gradients of 10 to 40% sucrose prepared in either pH 7.5 sodium phosphate buffer, 0.2 ionic strength, or pH 3 glycine-saline buffer, 0.1 ionic strength, were utilized. Centrifugation was performed by using an SW-39 rotor in the Spinco model E ultracentrifuge at 33,450 rpm for 16 hours. After centrifugation serial fractions were collected from the bottom of the tube. The activities of fractions from either the pH 3 or 7.5 gradients could be determined without prior dialysis. The buffers employed as diluents in the slide precipitin or latex fixation tests were sufficient to completely neutralize the relatively weak pH 3 buffer. Also there was no indication that the sucrose interfered with the activity measurements. In some experiments pooled fractions from the various levels of both neutral and acid gradients were analyzed after dialysis against pH 7.5 buffer. In all cases the results corresponded exactly to those obtained without prior dialysis.
Reactivity with aggregated '-globulin was determined by precipitin formation in'capillary tubes (24) for 'yA prepared in the goat were commercial products. 5 Ouchterlony agar diffusion studies (27) Figure 2 . Three preparations from patient Do were examined and gave essentially identical patterns. All demonstrated a small 7 S peak, a large broad 16 S peak, and a small amount of faster sedimenting materials separated poorly from the 16 S peak. The relative amounts of materials sedimenting at 16 S or faster were 83, 85, and 86%. Two preparations from Go and one from Od were examined. All demonstrated larger 7 S peaks than the Do preparations. The relative amounts of complexes in the Go preparations were 41 and 62%. About 50%o of the Od preparation sedimented as complexes. The various preparations dissociated completely in pH 4 sodium acetate buffer, 0.1 mole per L, and sedimented as a single symmetrical peak at 6 S. The sedimentation rate for human -yG (Cohn Fraction II) in the pH 4 buffer was the same as that observed for the dissociated complexes. The absence of fast sedimenting components after acid dissociation demonstrated that the preparations were relatively free of yM, which does not dissociate at low pH and continues to sediment rapidly (14) .
Ouchterlony agar diffusion indicated that, in addition to yG, the intermediate complex preparations contained at most trace amounts of -yM and yA antiserum formed weak lines and the anti-yM antisera formed very weak lines with the Go and Od preparations. No lines were detected with these antisera when the preparations were diluted to 1 mg per ml. The anti-yG antisera continued to give strong precipitin lines with the diluted preparations.
The activities of preparations from the three patients are listed in Table I . The various preparations from all three patients gave moderately strong or strong precipitates with aggregated y-globulin when tested at 10 mg per ml concentration. This precipitin activity could be detected at concentrations of 1 mg per ml or less. Substitution of saline for either the sample or the aggre- 
MENTS SHOWING THE DISTRIBUTION OF ANTI-y-GLOBULIN ACTIVITY IN AN INTERMEDIATE COMPLEX PREPARATION FROM PATIENT Do (UPPER SECTION) AND AN ACID-DISSOCI-ATED SAMPLE OF THE SAME PREPARATION (LOWER SECTION).
A pH 7.5 gradient was used for the experiment in the upper section and a pH 3 gradient in the lower. The gradient fractions are numbered from the bottom. Aggregated 'y-globulin precipitation and latex fixation are indicated. The activity of the intermediate complex preparation was associated with the faster sedimenting materials. After dissociation of the complexes, the activity was associated with the 7 S components.
at greater dilutions. Since the yM anti-y-globulins isolated from the same serum samples were highly active toward the coated human cells," it was not likely that the activities detected in the complex preparations were due to the presence of small amounts of yM anti-y-globulins. This conclusion was supported by the other findings of this study.
The activities of several samples each of preparations from Do and Od and one from Go were determined after ethyl mercaptan or mercaptoethanol treatment. The results are listed in Tables II and  III .°*~. faster sedimenting materials (i.e., the complexes). An acid-dissociated sample of the same preparation was fractionated simultaneously on a gradient prepared in pH 3 buffer. The results are illustrated in the lower section of Figure 3 . Dissociation of the complexes into their 7 S components was accompanied by a corresponding decrease in the sedimentation of the activity. These observations are representative of three such studies on preparations from this patient. Comparable results were also obtained with preparations from the other two patients. No yM activity was detected in any preparation examined by this method. Control experiments, with isolated yM anti-yglobulins or rheumatoid sera, demonstrated that this class of anti-y-globulins would have been recovered from the bottom (tubes 2 through 8) of either gradient. These experiments demonstrated clearly that the activities were associated with the acid-dissociable complexes.
Studies on aggregated y-globulin precipitates.
The active components contained in the intermediate complex preparations were further characterized by ultracentrifugal analysis of the precipitates formed with aggregated y-globulin. Before analysis, the precipitates were washed and dissolved in pH 3 buffer. Two preparations from patient Do and one each from Od and Go were examined by this technic. Examples of the resulting patterns are shown in Figure 4 . Each demonstrated a rapidly sedimenting broad boundary due to the aggregated y-globulin and a single component sedimenting at 7 S. No 19 S materials were detected in any of the samples analyzed.
The 7 S materials contained in dissolved precipitates were shown to be active by density gradient ultracentrifugal studies with pH 3 gradients. The results with a precipitate of a Go preparation are illustrated in Figure 5 . The anti-y-globulin activity was clearly associated with the 7 S components. Similar results were obtained with precipitates from the other two patients. The 7 S materials were also isolated from dissolved precipitates of intermediate complex preparations from patient Do by either preparatory ultracentrifugation or by gel filtration on Sephadex G-200 with the pH 3 buffer. The isolated materials, after dialysis into pH 7.5 buffer, formed intermediate complexes and precipitated with aggregated y-globulin. The ultracentrifugal pattern was quite similar to that of the preparation before precipitation.
Properties of the F(ab')2-fragments. Antibodies of the yG class have been shown to be cleaved by pepsin, in the absence of mercaptans, into bivalent fragments (18, 19) . These fragments, termed F(ab')9-fragments, sediment in the ultrac'entrifuge at class, it would be reasonable to expect their F(ab')2-fragments to be active. Samples of the various intermediate complex preparations were therefore subjected to this system of degradation and the resulting fragments characterized.
Examples of the ultracentrifugal patterns of the pepsin-digested complex preparations in pH 7.5 buffer are shown in Figures 6 and 7 . A minimum of two such preparations from each of the three patients were examined by this technic. The characteristic fast sedimenting complexes were absent after peptic digestion. Also, no 7 S materials were detected. The preparations contained large quantities of F (ab') 2-fragments sedimenting at 5.2 to 5.5 S. Small amounts of slower sedimenting components were also present. The effectiveness of the fragmentation procedure was also indicated by Ouchterlony agar diffusion studies on a representative preparation from each of the three patients. By using an antiserum to human Fraction II, the pepsin split complex preparations gave the expected reaction of partial identity with the untreated preparation (19) .
The activities of the F(ab')2-fragments and the corresponding untreated intermediate complex preparations are listed in Table IV . All the pepsin-digests examined (six from Do, four from Od, and two from Go) continued to precipitate strongly with aggregated y-globulin. Two of the digests from each patient were tested for latex fixation activity. Although the titers were comparable to the original material, the strengths of agglutination were sometimes less. This was especially apparent for some of the Go and Od fragment preparations. Conversion of the F(ab')2-fragments to the univalent fragments by reduction with 0.01 M cysteine and alkylation with 0.02 M iodoacetamide resulted in the expected loss of activity and decrease in sedimentation rate to 3.5 S. The F(ab')2-fragments did not agglutinate human red cells coated with incomplete anti-Rh antibody.
Peptic digestion of the yG molecule under the conditions utilized in this study results in the destruction of part of the molecule (18, 19) . For human -yG, this part is approximately equivalent to the fast-or Fc-fragment produced by papain cleavage. The absence of complexes in the intermediate complex preparations after peptic digestion, even though the resulting fragments demonstrated anti-y-globulin activity, indicated that the Figure 6 . A large amount of complexes sedimenting at 8.6 S and a small amount sedimenting at a faster rate were present in the mixture. This was accompanied by a corresponding decrease in the quantity of 5 S fragments. The complexes were dissociated into 5 and 6 S components after dialysis into 0.1 M sodium acetate buffer, pH 4.1. Essentially identical results were obtained with a second fragment preparation from this patient.
The results of a similar experiment with an F(ab')2-fragment preparation from patient Od are shown in Figure 7 . Although the results were not as dramatic as with the fragments from patient Do, the formation of complexes after the addition of yG was apparent. These sedimented at approximately 9 and 11 S and were dissociated after dialysis into the pH 4. nents about equal in size sedimenting at about 5 and 6 S. These observations were confirmed by using a second fragment preparation from this patient. The results obtained when human yG was added to fragment preparations from patient Go were similar to those shown for the fragment preparation from patient Od.
The active components in two F(ab')2-fragment preparations from patient Do and one from Od were further characterized by ultracentrifugal analysis of the materials precipitated by aggregated y-globulin (Figure 8 ). Before analysis, the precipitates were washed and dissolved in pH 3 buffer. In addition to the aggregates, only a single 5 S component was detected. It was not possible to examine Go fragments by this method due to the limited supply of serum from this patient. Density~gradient ultracentrifugal studies of the dissolved precipitates on pH 3 gradients provided additional evidence that the anti-y-globulin activity was associated with the 5 S materials. Similar results were obtained when a fragment preparation from patient Do was analyzed on a pH 7.5 gradient. Direct evidence that the activity was indeed associated with the 7 S components of the complexes was obtained by density gradient ultracentrifugal studies of acid-dissociated preparations. These studies failed to show the presence of yM (19 S) activity. Only 7 S activity was detected. Control studies demonstrated that yM anti-y-globulin activity would have been easily detected by this technique. Similarly, analytical ultracentrifugal analyses of the materials precipitated by aggregated y-globulin, dissolved in pH 3 buffer, revealed only large quantities of 7 S materials. These materials, isolated from the dissolved precipitates, were shown to be active and to form complexes.
The results of the peptic digestion studies were consistent with those expected for a typical yGantibody (18, 19) . After digestion, the preparations sedimented at 5 S and continued to react in the tests for anti-y-globulin activity. The activity was shown by a number of studies to be associated with the 5 S fragments and not undigested material. The absence of detectable amounts of components sedimenting faster than 5 S indicated a minimum of undigested material. The distribution of activity in a pepsin-digest was observed to correspond to the 5 S materials by density gradient ultracentrifugation. Analytical ultracentrifugal analyses of the materials precipitated by aggregated y-globulin from pepsin-digests demonstrated only 5 S components. The fragments eluted from the precipitates were shown to be active by density gradient ultracentrifugation. The activity of the pepsin-digests differed from that of the untreated preparations in that it was sensitive to treatment by mercaptans. This sensitivity is consistent with that demonstrated for the 5 S fragments produced from antibodies by peptic digestion (18) . The specificity of these yG anti-yglobulins was also evident from the digestion studies. The absence of complexes in the pepsin-digests at neutral pH indicated that the group or groups that react with the active sites to form complexes were destroyed. This was further indicated by the formation of complexes with unaltered yG.
From the results of these studies it is apparent that the yG factors responsible for the formation of intermediate complexes are antibodies specific for one or more groups on the part of the yG molecule destroyed by peptic digestion. Intermediate complexes are therefore formed by the binding of yG to the active sites of yG anti-y-globulins. Some evidence that the intermediate complexes represent antigen-antibody complexes was also obtained by Kunkel, Muller-Eberhard, Fudenberg, and Tomasi (14) . It was found that the addition of yG to sera or euglobulin fractions produced marked effects on the ultracentrifugal distribution of the complexes. Those complexes sedimenting at 10 S were increased at the expense of those sedimenting at faster rates. The effect of the excess yG suggested the action of excess antigen on antigen-antibody complexes. In contrast to the present study, efforts by these workers to demonstrate an anti-y-globulin activity for the complexes by various serological tests were not successful. The reason for this is not apparent. However, in a later study, Chodirker and Tomasi (16) demonstrated an anti-y-globulin activity by the latex fixation test in fractions that contained intermediate complexes, but were free of yM. These fractions were isolated from sera by ion exchange chromatography or density gradient ultracentrifugation. In contrast to control rheumatoid sera, considerable activity remained in sera containing complexes after mercaptoethanol treatment. The active components and the specificity were not characterized further. A cryoglobulin of the yG class that had the properties of the intermediate complexes and precipitated with aggregated y-globulin has also been reported (17) . The activity was not sensitive to mercaptoethanol treatment and was shown to be associated with the 7 S components.
The classical yM anti-y-globulins also react with antigenic determinants in the part of the yG molecule destroyed by peptic digestion (19, 29) . Since this part of the molecule appears to contain several such determinants (12) , the exact relationships of the specificities of the two classes of antiy-globulins will require additional studies. The difference in the capacity of the yM and yG anti-yglobulins from the same patient to agglutinate sensitized red cells suggests that the specificities are not identical. Since the yM anti-y-globulins in individual sera can be heterogeneous with respect to reactivity in various test systems (30) , it is possible that some molecules of corresponding specificity exist. The possibility also exists that this may reflect differences in avidity or agglutinating efficiency. Such differences have been demonstrated for other yM and yG antibodies (31) . Inhibition as a factor in the failure of the yG anti-yglobulins to agglutinate sensitized cells seems unlikely since the F(ab')2-fragments of the preparations also failed to agglutinate sensitized human cells. The potentially inhibitory part of the yG molecule was destroyed by the digestion procedure (19) .
The accumulated evidence from this and other laboratories indicates that the anti-y-globulins responsible for intermediate complex formation are yG counterparts to the classical yM anti-y-globulins.
The existence of such counterparts constitutes additional evidence that the rheumatoid factors represent an immune response to some form of yG.
The existence of both yG and yM anti-y-globulins of similar specificities is consistent with the known molecular heterogeneity of antibodies. The simultaneous presence of activity in all three major classes of immunoglobulins has been demonstrated for a variety of human antibodies, including antinuclear (32) and antithyroglobulin (33) factors. Also pertinent in this respect is the reported identification of /A anti-y-globulin factors that are reactive with human and rabbit y-globulin (34) . The existence of human -yG anti-y-globulins is also consistent with the production of both 7 S and 19 S anti-y-globulin factors in rabbits immunized with altered autologous y-globulin (35) . The production of both -yM and yG antibodies in response to a single antigen commonly occurs in a variety of species, including humans (36-39). The -yM antibodies have been shown to be the first antibodies produced in response to an antigenic stimulus. The yG antibodies usually appear later and frequently persist over a longer period of time. Often repeated or larger doses of antigen are required to produce yG antibodies. The incidence and distribution of the intermediate complexes appears compatible with these experimental data concerning the relationships of the yG and yM antibodies. Although exact information is not available, it is known that complexes are found in large quantities in only a limited number of patients and are usually associated with high titers of yM antiy-globulin activity (14) .
A group of -yG anti-y-globulins that are specific for antigenic determinants in human -yG revealed by peptic digestion have been described (19) . These factors do not form complexes and are clearly distinguished from the anti-y-globulins responsible for intermediate complex formation in their specificity and serological activity. These factors agglutinate red cells coated with the Fabor F(ab')2-fragments of an incomplete anti-Rh antibody but do not react in the common tests for rheumatoid factor activity.
Summary
Preparations containing significant amounts of y-globulin complexes of the intermediate type were isolated from the sera of three patients with rheumatoid arthritis. The preparations precipitated heat-aggregated y-globulin and agglutinated latex particles coated with Fraction II y-globulin. Evidence from a variety of studies demonstrated that the anti-y-globulin activities were not due to the presence of small amounts of yM (19 S) anti-yglobulins, but were associated with the yG (7 S) components of the complexes.
The complex preparations were degraded by peptic digestion to fragments that sedimented at 5 S. Complexes and 7 S materials were not pres-ent after digestion. The fragments demonstrated anti-y-globulin activities similar to those of the original preparations and were found to form complexes with unaltered human -yG.
The results provide evidence that the yG factors responsible for the formation of the intermediate complexes are antibodies that are specific for groups on the part of the yG molecule destroyed by peptic digestion. This group of anti-y-globulins appears to represent -yG counterparts to the classical /M anti-y-globulins (19 S rheumatoid factors).
